Earnings Call
Apr 16, 2026
Q1 FY2026
EPS Estimate
1.14
EPS Actual
1.15
Post-Earnings Close
$95.47
Earnings Reaction
-6.0%
Abbott's Q1 2026 results came in at adjusted EPS of $1.15, a penny above the $1.14 consensus estimate, on comparable sales growth of 3.7%. The quarter was shaped by two notable headwinds that management characterized as transitory: a respiratory testing season that came in weaker than even Abbott's already-conservative internal forecast, and the absorption of earlier-than-planned financing costs tied to the March 23 close of the Exact Sciences acquisition. That the company still delivered 6% EPS growth despite both drags speaks to the underlying resilience of the portfolio, though the headline comparable growth rate of 3.7% will invite scrutiny given the full-year 6.5%, 7.5% comparable sales growth target.
Report generated on Apr 16, 2026
AI-generated earnings analysis. Not investment advice.
Chief Executive Officer
The quarter's results reflected a combination of company-specific execution and broader sector dynamics, with management addressing several of the key debates that analysts had flagged heading into the print. Guidance commentary pointed to continued momentum in the core segments, while questions on margins and capital allocation drew more nuanced responses from the leadership team over the course of the call.
The quarter's results reflected a combination of company-specific execution and broader sector dynamics, with management addressing several of the key debates that analysts had flagged heading into the print. Guidance commentary pointed to continued momentum in the core segments, while questions on margins and capital allocation drew more nuanced responses from the leadership team over the course of the call.
The quarter's results reflected a combination of company-specific execution and broader sector dynamics, with management addressing several of the key debates that analysts had flagged heading into the print. Guidance commentary pointed to continued momentum in the core segments, while questions on margins and capital allocation drew more nuanced responses from the leadership team over the course of the call.
Read the full ABT analysis
The complete report, with key themes, analyst Q&A summary, notable quotes, and market context — is free with an account. No password, no card.